232 related articles for article (PubMed ID: 8180669)
1. Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody.
Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
Eur J Endocrinol; 1994 May; 130(5):438-45. PubMed ID: 8180669
[TBL] [Abstract][Full Text] [Related]
2. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
Leaños A; Pascoe D; Fraga A; Blanco-Favela F
Lupus; 1998; 7(6):398-403. PubMed ID: 9736323
[TBL] [Abstract][Full Text] [Related]
3. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
Hattori N; Inagaki C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3107-10. PubMed ID: 9284753
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia.
Hattori N; Ishihara T; Ikekubo K; Moridera K; Hino M; Kurahachi H
J Clin Endocrinol Metab; 1992 Nov; 75(5):1226-9. PubMed ID: 1430082
[TBL] [Abstract][Full Text] [Related]
5. Effects of anti-prolactin autoantibodies on serum prolactin measurements.
Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
Eur J Endocrinol; 1994 May; 130(5):434-7. PubMed ID: 8180668
[TBL] [Abstract][Full Text] [Related]
6. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
Hattori N
J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
[TBL] [Abstract][Full Text] [Related]
7. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
[TBL] [Abstract][Full Text] [Related]
8. Macroprolactinemia: a new cause of hyperprolactinemia.
Hattori N
J Pharmacol Sci; 2003 Jul; 92(3):171-7. PubMed ID: 12890882
[TBL] [Abstract][Full Text] [Related]
9. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
10. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
Shimatsu A; Hattori N
Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
[TBL] [Abstract][Full Text] [Related]
11. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
J Clin Endocrinol Metab; 2001 Jun; 86(6):2619-24. PubMed ID: 11397862
[TBL] [Abstract][Full Text] [Related]
12. Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients.
Blanco-Favela F; Quintal MaG ; Chavez-Rueda AK; Leaños-Miranda A; Berron-Peres R; Baca-Ruiz V; Lavalle-Montalvo C
Lupus; 2001; 10(11):803-8. PubMed ID: 11789490
[TBL] [Abstract][Full Text] [Related]
13. Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women.
Pascoe-Lira D; Duran-Reyes G; Contreras-Hernández I; Manuel-Apolinar L; Blanco-Favela F; Leaños-Miranda A
J Clin Endocrinol Metab; 2001 Feb; 86(2):924-9. PubMed ID: 11158068
[TBL] [Abstract][Full Text] [Related]
14. Antiprolactin autoantibodies are associated with hyperprolactinemic status in men infected with human immunodeficiency virus.
Leaños-Miranda A; Contreras-Hernández I
Endocrine; 2002 Nov; 19(2):139-46. PubMed ID: 12588043
[TBL] [Abstract][Full Text] [Related]
15. Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia.
Hattori N; Nakayama Y; Kitagawa K; Ishihara T; Saiki Y; Inagaki C
J Endocrinol; 2006 Aug; 190(2):287-93. PubMed ID: 16899562
[TBL] [Abstract][Full Text] [Related]
16. A normal ovulatory woman with hyperprolactinemia: presence of anti-prolactin autoantibody and the regulation of prolactin secretion.
Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
Acta Endocrinol (Copenh); 1992 Jun; 126(6):497-500. PubMed ID: 1642083
[TBL] [Abstract][Full Text] [Related]
17. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
Cavaco B; Leite V; Santos MA; Arranhado E; Sobrinho LG
J Clin Endocrinol Metab; 1995 Aug; 80(8):2342-6. PubMed ID: 7629227
[TBL] [Abstract][Full Text] [Related]
18. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
Davajan V; Kletzky O; March CM; Roy S; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142
[TBL] [Abstract][Full Text] [Related]
19. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes.
De Schepper J; Schiettecatte J; Velkeniers B; Blumenfeld Z; Shteinberg M; Devroey P; Anckaert E; Smitz J; Verdood P; Hooghe R; Hooghe-Peters E
Eur J Endocrinol; 2003 Sep; 149(3):201-7. PubMed ID: 12943522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]